Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Lucia Robado de Lope"'
Autor:
Lucia Robado de Lope, Estela Sánchez‐Herrero, Roberto Serna‐Blasco, Mariano Provencio, Atocha Romero
Publikováno v:
Molecular Oncology, Vol 17, Iss 3, Pp 390-406 (2023)
Cancer is conventionally considered an evolutionary disease where tumor cells adapt to the environment and evolve eventually leading to the formation of metastasis through the seeding and growth of metastasis‐initiating cells in distant organs. Tum
Externí odkaz:
https://doaj.org/article/dcda7a73dad944309730a4a8d8e8b51a
Autor:
Estela Sánchez-Herrero, Roberto Serna-Blasco, Lucia Robado de Lope, Víctor González-Rumayor, Atocha Romero, Mariano Provencio
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Cancer cells release nucleic acids, freely or associated with other structures such as vesicles into body fluids, including blood. Among these nucleic acids, circulating tumor DNA (ctDNA) has emerged as a minimally invasive biomarker for tumor molecu
Externí odkaz:
https://doaj.org/article/b2ecac58b9f245bb9ac91ce5a3cb6d2a
Autor:
Lucia Robado de Lope, Estela Sánchez‐Herrero, Roberto Serna‐Blasco, Mariano Provencio, Atocha Romero
Publikováno v:
Molecular Oncology. 17:390-406
Cancer is conventionally considered an evolutionary disease where tumor cells adapt to the environment and evolve eventually leading to the formation of metastasis through the seeding and growth of metastasis-initiating cells in distant organs. Tumor
Autor:
Henrik Uwe Stotz, Ajisa Muthayil Ali, Lucia Robado de Lope, Mohammed Sajid Rafi, Georgia Konstantinou Mitrousia, Yong‐Ju Huang, Bruce David Ledger Fitt
Publikováno v:
Pest Management Science.
Autor:
Ana Giménez‐Capitán, Estela Sánchez‐Herrero, Lucía Robado de Lope, Andrés Aguilar‐Hernández, Ivana Sullivan, Virginia Calvo, Irene Moya‐Horno, Santiago Viteri, Carlos Cabrera, Cristina Aguado, Noelia Armiger, Joselyn Valarezo, Clara Mayo‐de‐las‐Casas, Noemí Reguart, Rafael Rosell, Mariano Provencio, Atocha Romero, Miguel A. Molina‐Vila
Publikováno v:
Molecular Oncology, Vol 17, Iss 9, Pp 1884-1897 (2023)
ALK, ROS1, and RET fusions and MET∆ex14 variant associate with response to targeted therapies in non‐small‐cell lung cancer (NSCLC). Technologies for fusion testing in tissue must be adapted to liquid biopsies, which are often the only material
Externí odkaz:
https://doaj.org/article/895f32ea609d4f95922800c025292cd9